If you wish to have your article included on the GESA website please email us at gesa@gesa.org.au
10 February 2022
The Medical Costs Finder is an online tool designed to reduce ‘bill-shock’ for consumers from unexpected out-of-pocket medical expenses.
Read More17 January 2022
As Omicron case numbers grow, the Australian Government will make temporary changes to Telehealth introducing temporary specialist inpatient telehealth MBS items available until 30 June 2022. For full details please refer to the joint statement made by The Hon. Greg Hunt MP Minister for Health and Aged Care and The Hon. David Gillespie MP Minister for Regional Health below.
Read More07 May 2021
Up-to-date information and tools are now available from the Targeted Therapies Alliance to help support gastroenterologists, GPs and nurses to optimise the safety and health outcomes of biological and other specialised medicines for inflammatory bowel disease (IBD).
Read More06 May 2021
A new report commissioned by The Liver Foundation reveals the social and economic impact of liver cancer on Australians and on the health system. With estimated 1916 new HCC cases diagnosed, particularly between 55-59 years of age, the total cost of HCC in Australia in 2019-2020 was estimated to be $4.8 billion. This comprehensive report provides essential data to support the need for increased funding for research, prevention and therapy in HCC.
Read More08 January 2018
Coeliac disease, an allergy to gluten that causes damage to the intestine, affects 1% of Australians. But more than ten times this number, or around 11% of the population, follows a gluten-free diet by choice, and up to 30% of people in the United States try to reduce their gluten intake.
Read More12 December 2017
Heartbreaking is the only way to describe the surprising news that four out of every ten Australian men who now die of cancer could potentially have avoided it.
Read More30 November 2017
The Gastroenterological Society of Australia (GESA) is urging the Federal Government to prioritise liver cancer including through the funding of checkpoint inhibitors.
Read More29 November 2017
The Gastroenterological Society of Australia (GESA) has urged government to prioritise liver cancer, including the funding of new immunotherapies
Read More15 November 2017
The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased and easier, non-invasive ways of assessing the disease have become available in recent years but there is still a concerning under-recognition of the disease.
Read More05 October 2017
Clinicians including specialists and GPs need to check their language and behaviour around a diagnosis of IBS.
Read More04 October 2017
Myths abound for women with IBD who want to start a family so it is important for gastroenterologists to be proactive and start discussions with their patients early, an expert advises.
Read More21 September 2017
Gastroenterologist Dr Cameron Bell has been recognised for his contributions to the profession and to GESA with the Society’s 2017 Distinguished Service Award, presented at Australian Gastroenterology Week.
Read More05 September 2017
A proportion of non-responders to faecal microbiota transplantation (FMT) for recurrent C. difficile infection probably have a post-infectious IBS rather than the intestinal infection.
Read More04 September 2017
Twenty new colonoscopy items will soon be added to the Medicare Benefits Schedule, to replace two “outdated” codes.
Read More22 August 2017
A consensus statement from GESA, Gastroenterological Nurses College of Australia (GENCA), Australasian College for Infection Prevention and Control (ACIPC) and Australasian Society for Infectious Disease (ASID) recommends all endoscopic equipment is stored in TGA-approved forced-air drying cabinets.
Read More21 August 2017
Delegates who attended an AGW 17 session on the recently released IBD Audit were treated to a guest speaker not usually seen at an annual clinical conference – a patient.
Read More20 August 2017
A balanced career incorporating clinical work, teaching and research has earned Sydney gastroenterologist Professor Michael Grimm the GESA 2017 Outstanding Clinician Award.
Read More27 May 2017
NOD-like receptor protein 3 (NLRP3) inflammasome activation occurs in Non-alcoholic fatty liver disease (NAFLD).
Read More05 March 2017
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive detection methods, and this increase is creating challenges for clinical management.
Read More28 September 2016
The mechanisms that promote liver injury in non-alcoholic fatty liver disease (NAFLD) are yet to be thoroughly elucidated.
Read More29 February 2016
Chronic hepatitis C virus (HCV) infection affects 230,000 people in Australia, who are at risk of progressive liver fibrosis leading to cirrhosis, liver failure and hepatocellular carcinoma. The burden of liver disease due to HCV is projected to triple by 2030.
Read More09 February 2016
The peak Australian body for the treatment of liver diseases – the Gastroenterological Society of Australia Australian Liver Association (GESA ALA) – reaffirms its ongoing collaboration with general practitioners in the treatment of hepatitis C.
Read More
GESA is a not-for-profit organisation
3/517 Flinders Lane
Melbourne VIC 3000 Australia
Email: gesa@gesa.org.au
Phone: 1300 766 176
ABN: 44 001 171 115
GESA's business hours are 8:30am - 5:30pm Monday to Friday. The office will be closed on Victorian and national public holidays.
GESA is an ACNC-registered health-promotion charity with 'deductible gift recipient' status
For all course, event and stakeholder engagement inquiries contact us at gesa@gesa.org.au or on 1300 766 176.
For all media and social media inquiries please contact the GESA Communications Team at mediaenquiry@gesa.org.au or on1300 766 176.
For membership information please contact the GESA Membership Team at memberservices@gesa.org.au or on
1300 766 176.
Images used on this site may include stock photos and the associated information may not represent the personal situation, views or beliefs of the people in the images.